Literature DB >> 10862037

Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.

S Kytölä1, J Rummukainen, A Nordgren, R Karhu, F Farnebo, J Isola, C Larsson.   

Abstract

Breast cancer cell lines have been widely used as models in functional and therapeutical studies, but their chromosomal alterations are not well known. We characterized the chromosomal aberrations in 15 commonly used human breast carcinoma cell lines (BT-474, BT-549, CAMA-1, DU4475, MCF7, MDA-MB-134, MDA-MB-157, MDA-MB-361, MDA-MB-436, MPE600, SK-BR-3, T-47D, UACC-812, UACC-893, and ZR-75-1) by comparative genomic hybridization (CGH) and spectral karyotyping (SKY). By CGH the most frequent gains were detected at 1q, 8q, 20q, 7, 11q13, 17q, 9q, and 16p, whereas losses were most common at 8p, 11q14-qter, 18q, and Xq. SKY revealed a multitude of structural and numerical chromosomal aberrations. Simple translocations, typically consisting of entire translocated chromosome arms, were the most common structural aberrations. Complex marker chromosomes included material from up to seven different chromosomes. Evidence for a cytogenetic aberration not previously described in breast cancer, the isoderivative chromosome, was found in two cell lines. Translocations t(8;11), t(12;16), t(1;16), and t(15;17) were frequently found, although the resulting derivative chromosomes and their breakpoints were strikingly dissimilar. The chromosomes most frequently involved in translocations were 8, 1, 17, 16, and 20. An excellent correlation was found between the number of translocation events found by SKY in the individual cell lines, and the copy number gains and losses detected by CGH, indicating that the majority of translocations are unbalanced. Genes Chromosomes Cancer 28:308-317, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862037     DOI: 10.1002/1098-2264(200007)28:3<308::aid-gcc9>3.0.co;2-b

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  43 in total

1.  End-sequence profiling: sequence-based analysis of aberrant genomes.

Authors:  Stanislav Volik; Shaying Zhao; Koei Chin; John H Brebner; David R Herndon; Quanzhou Tao; David Kowbel; Guiqing Huang; Anna Lapuk; Wen-Lin Kuo; Gregg Magrane; Pieter De Jong; Joe W Gray; Colin Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-04       Impact factor: 11.205

2.  Whole-genome shotgun optical mapping of Rhodospirillum rubrum.

Authors:  Susan Reslewic; Shiguo Zhou; Mike Place; Yaoping Zhang; Adam Briska; Steve Goldstein; Chris Churas; Rod Runnheim; Dan Forrest; Alex Lim; Alla Lapidus; Cliff S Han; Gary P Roberts; David C Schwartz
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

3.  Limited tissue fixation times and whole genomic amplification do not impact array CGH profiles.

Authors:  A A Ghazani; N C R Arneson; K Warren; S J Done
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

4.  A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome.

Authors:  Oliver A Hampton; Petra Den Hollander; Christopher A Miller; David A Delgado; Jian Li; Cristian Coarfa; Ronald A Harris; Stephen Richards; Steven E Scherer; Donna M Muzny; Richard A Gibbs; Adrian V Lee; Aleksandar Milosavljevic
Journal:  Genome Res       Date:  2008-12-03       Impact factor: 9.043

5.  Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs).

Authors:  Yijun Ruan; Hong Sain Ooi; Siew Woh Choo; Kuo Ping Chiu; Xiao Dong Zhao; K G Srinivasan; Fei Yao; Chiou Yu Choo; Jun Liu; Pramila Ariyaratne; Wilson G W Bin; Vladimir A Kuznetsov; Atif Shahab; Wing-Kin Sung; Guillaume Bourque; Nallasivam Palanisamy; Chia-Lin Wei
Journal:  Genome Res       Date:  2007-06       Impact factor: 9.043

6.  DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells.

Authors:  Zhiyong Mao; Ying Jiang; Xiang Liu; Andrei Seluanov; Vera Gorbunova
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

7.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

8.  Genome-wide appraisal of thyroid cancer progression.

Authors:  Volkert B Wreesmann; Ronald A Ghossein; Snehal G Patel; Charles P Harris; Erik A Schnaser; Ashok R Shaha; R Michael Tuttle; Jatin P Shah; Pulivarthi H Rao; Bhuvanesh Singh
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

9.  Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.

Authors:  Emilia Wiechec; Jens Overgaard; Eigil Kjeldsen; Lise Lotte Hansen
Journal:  Cell Oncol (Dordr)       Date:  2012-12-18       Impact factor: 6.730

10.  Activation of estrogen-responsive genes does not require their nuclear co-localization.

Authors:  Silvia Kocanova; Elizabeth A Kerr; Sehrish Rafique; Shelagh Boyle; Elad Katz; Stephanie Caze-Subra; Wendy A Bickmore; Kerstin Bystricky
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.